Japanese
English
Home
About Us
Message from CEO
Our Mission
Our Business
Corporate Information
Leadership/ Governance
Access
Our Science
PRIME Technology
Application of Our Technology
Pipelines
Our Partners
IR
IR News
Management
Top Message
Corporate Governance
Disclosure Policy
Financial Highlights
IR Library
Financial Results
Presentation Materials
Securities Report
IR Materials
For Shareholders
Stock Overview
General Meeting of Shareholders
Stock Quotations
IR Calendar
IR FAQ
IR Contact
Disclaimer
Careers
Contact Us
Contact Us
Create the Future to Overcome Cancer
News
2025/07/16
Notice of Project Adoption for Ube City Subsidy for Promoting Practical Application of Cutting-Edge Research and Development in Regenerative Medicine, etc.
2025/07/15
Notice of Ending Collaboration with Daiichi Sankyo on Technology Assessment
2025/07/01
Notice of Subsidy Project Adoption for FY2025 Yamaguchi Advancements in Practical Application and Industrialization of Regenerative Medicine
2025/06/09
Notice of Completion of Clinical Trial Notification Submission of NIB103 Phase I Clinical Trial
2025/06/03
Poster Presentation at the American Society of Clinical Oncology (ASCO) for Phase I Study on Safety and Efficacy of Switchable CAR-T Cell Therapy with FY001 and CART001 in Patients with Relapsed/Refractory CD20-positive B-cell Non-Hodgkin Lymphoma (EPOC1803)
Details
